LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,178
تعداد مقالات10,740
تعداد مشاهده مقاله70,472,910
تعداد دریافت فایل اصل مقاله12,469,975
Saberian, Peyman, Pazooki, Behshad, Hasani-Sharamin, Parisa, Garjani, Khazar, Ahmadi Hatam, Zohreh, Dadashi, Fatemeh, Baratloo, Alireza. (1401). Persistent/Late-Onset Complications of COVID-19 in General Population: A Cross- Sectional Study in Tehran, Iran. سامانه مدیریت نشریات علمی, 10(3), 234-245. doi: 10.30476/ijcbnm.2022.93302.1917
Peyman Saberian; Behshad Pazooki; Parisa Hasani-Sharamin; Khazar Garjani; Zohreh Ahmadi Hatam; Fatemeh Dadashi; Alireza Baratloo. "Persistent/Late-Onset Complications of COVID-19 in General Population: A Cross- Sectional Study in Tehran, Iran". سامانه مدیریت نشریات علمی, 10, 3, 1401, 234-245. doi: 10.30476/ijcbnm.2022.93302.1917
Saberian, Peyman, Pazooki, Behshad, Hasani-Sharamin, Parisa, Garjani, Khazar, Ahmadi Hatam, Zohreh, Dadashi, Fatemeh, Baratloo, Alireza. (1401). 'Persistent/Late-Onset Complications of COVID-19 in General Population: A Cross- Sectional Study in Tehran, Iran', سامانه مدیریت نشریات علمی, 10(3), pp. 234-245. doi: 10.30476/ijcbnm.2022.93302.1917
Saberian, Peyman, Pazooki, Behshad, Hasani-Sharamin, Parisa, Garjani, Khazar, Ahmadi Hatam, Zohreh, Dadashi, Fatemeh, Baratloo, Alireza. Persistent/Late-Onset Complications of COVID-19 in General Population: A Cross- Sectional Study in Tehran, Iran. سامانه مدیریت نشریات علمی, 1401; 10(3): 234-245. doi: 10.30476/ijcbnm.2022.93302.1917

Persistent/Late-Onset Complications of COVID-19 in General Population: A Cross- Sectional Study in Tehran, Iran

International Journal of Community Based Nursing & Midwifery
مقاله 7، دوره 10، شماره 3 - شماره پیاپی 39، مهر 2022، صفحه 234-245    اصل مقاله (850.28 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/ijcbnm.2022.93302.1917
نویسندگان
Peyman Saberian1، 2؛ Behshad Pazooki3؛ Parisa Hasani-Sharamin4؛ Khazar Garjani1؛ Zohreh Ahmadi Hatam4؛ Fatemeh Dadashi4؛ Alireza Baratloo* 1
1Prehospital and Hospital Emergency Research Center, Department of Emergency Medicine, Tehran University of Medical Sciences, Tehran, Iran;
2Department of Anesthesiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran;
3Department of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran;
4Tehran Emergency Medical Service Center, Tehran, Iran
چکیده
Background: After recovery from acute phase of the COVID-19, some patients suffer from persistent/late-onset complications. The main objective of this study was to investigate the prevalence of such complications in a large scale of COVID-19 patients in Tehran, Iran.
Methods: In this cross-sectional study, those patients who called Tehran emergency medical services center and were visited by the emergency medical technicians from 20 March 2020 until 21 September 2020 and diagnosed as a confirmed COVID-19 case were enrolled. The minimum required sample size was estimated 385 cases, and they were selected randomly. The patients were interviewed by phone at least 4 weeks since initiation of their symptoms. Using a pre-prepared checklist, made by an expert panel who were involved in management of COVID-19 patients, data were collected on the types and duration of the complications, clinical information, and factors which could interfere with developing the complications. All analyses were performed using STATA 16 software. The association of the prevalence of each complication with independent factor was assessed using Chi-square test (or Fisher’s exact test) for categorical variable, and the mean difference of numerical variables in the two groups (with and without complication) was assessed using independent t-test. Statistical significance was accepted at P value<0.05.
Results: Four-hundred forty-seven patients participated in the study. Among our total population, 345 (77.2%) patients experienced at least one of the persistent/late-onset complications. Cardiopulmonary and then skin-related symptom categories were reported in 179 (40.0%) and 173 (38.7%) patients, respectively, and were the most prevalent persistent/late-onset complications. The associations of long term persistent/late-onset complications with older ages (P=0.04), female (P<0.001), psychological stress (P=0.01), and inadequate rest after illness (P<0.001) were significant.
Conclusion: The findings of this study indicate that a significant number of patients will experience persistent/late-onset complications, both physically and mentally, after recovering from acute phase of COVID-19. Thus, physicians should have adequate resources and support to care for the patients to help them cope with the condition.
کلیدواژه‌ها
Medically unexplained symptoms؛ COVID-19؛ Post-acute COVID-19 syndrome
سایر فایل های مرتبط با مقاله
مراجع
1.    Vahidi E, Jalili M. Why COVID-19? Frontiers in Emergency Medicine. 2020;4:e36.
2.    Bryson WJ. Long-term health-related quality of life concerns related to the COVID-19 pandemic: a call to action. Quality of Life Research. 2021;30:643-5.
3.    The Lancet. Facing up to long COVID. Lancet. 2020;396:1861.
4.    Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nature Medicine. 2021;27:601-15.
5.    SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. Late Complications of COVID-19; a Systematic Review of Current Evidence. Archives of Academic Emergency Medicine. 2021;9:e14.
6.    Naderpour Z, Saeedi M. A primer on covid-19 for clinicians: clinical manifestation and natural course. Frontiers in Emergency Medicine. 2020;4:e62.
7.    Mandal S, Barnett J, Brill SE, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396-8.
8.    Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5:1265-73.
9.    Lu Y, Li X, Geng D, et al. Cerebral micro-structural changes in COVID-19 patients–an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484.
10.    Moradian ST, Parandeh A, Khalili R, Karimi L. Delayed symptoms in patients recovered from COVID-19. Iranian Journal of Public Health. 2020;49:2120-7.
11.    Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. Journal of Neurovirology. 2021;27:154-9.
12.    Sepehrinezhad A, Shahbazi A, Negah SS. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. Journal of Neurovirology. 2020;26:324-9.
13.    World Health Organization. WHO COVID-19 Case definition. Geneva: World Health Organization; 2020.
14.    Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603-5.
15.    Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Archives of General Psychiatry. 2003;60:184-9.
16.    Kessler RC, Green JG, Gruber MJ, et al. Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. International Journal of Methods in Psychiatric Research. 2010;19:4-22.
17.    Dadfar M, Atef Vahid M, Lester D, Bahrami F. Kessler Psychological Distress Scale (K6): Psychometric Testing of the Farsi Form in Psychiatric Outpatients. Advances in Bioresearch. 2016;7:105-8.
18.    Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March–June 2020. Morbidity and Mortality Weekly Report. 2020;69:993-8.
19.    Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal of Medical Virology. 2021;93:1013-22.
20.    Osikomaiya B, Erinoso O, Wright KO, et al. ‘Long COVID’: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infectious Diseases. 2021;21:304.
21.    Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Network Open. 2021;4:e2111417.
22.    Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Journal of Infection. 2020;80:e14-8.
23.    Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
24.    Islam MS, Ferdous MZ, Islam US, et al. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. International Journal of Environmental Research and Public Health. 2021;18:1453.
25.    Jacob L, Tully MA, Barnett Y, et al. The relationship between physical activity and mental health in a sample of the UK public: A cross-sectional study during the implementation of COVID-19 social distancing measures. Mental Health and Physical Activity. 2020;19:100345.
26.    Zandifar A, Badrfam R, Yazdani S, et al. Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19. Journal of Diabetes & Metabolic Disorders. 2020;19:1-8.
27.    Tleyjeh IM, Saddik B, AlSwaidan N, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PloS One. 2021;16:e0260568.

آمار
تعداد مشاهده مقاله: 3,974
تعداد دریافت فایل اصل مقاله: 2,273


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب